Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns

被引:30
作者
Ramirez-Cacho, WA [1 ]
Flores, S [1 ]
Schrader, RM [1 ]
McKay, J [1 ]
Rayburn, WF [1 ]
机构
[1] Univ New Mexico, Div Maternal Fetal Med, Dept Obstet & Gynecol, Albuquerque, NM 87111 USA
关键词
methadone; fetal heart rate; substance use; intrapartum monitoring;
D O I
10.1016/j.jsgi.2005.11.001
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Treatment of maternal opioid dependence with methadone is associated with a delay in fetal heart rate (FHR) accelerations in nonstress tests. The objective of this investigation was to determine the effect of methadone maintenance therapy on intrapartum FHR patterns. METHODS: This retrospective cohort study compared intrapartum FHR tracings from 56 methadone-treated patients >= 36 weeks gestation with a control group of nonsubstance using patients matched for maternal age, parity, gestational age, and ethnicity. Blinded FHR interpretation included the recording of baseline, variability, accelerations, and late or sever variable decelerations. The 8-point FHR scoring system was based on the National Institute of Child Health and Human Development Research Planning Workshop guidelines. We considered a 25% reduction in the score during the latent phase to be significant. RESULTS: The median maintenance dose of methadone was 70 mg daily, with a range between 20 mg and 130 mg. Each patient tested negative for other substances on urine screening before admission. The significantly lower FHR score in the methadone group (mean difference, 1.4; 95% confidence interval, 1.1 to 1.7) was attributed to a lower baseline (P < .05), less moderate or marked variability (P < .01), and a lower proportion of accelerations during the first stage of labor (P < .01). A higher proportion of methadone-exposed fetuses had late or severe variable decelerations in the second stage (44.2% vs 22.9%; P < .03). Analgesic needs, operative vaginal or cesarean delivery rates, and Apgar scores less than 7 at 1 and 5 minutes were not significantly different between the two groups. CONCLUSIONS: Chronic maternal methadone treatment affects intrapartum FHR patterns by reducing the variability, baseline, and proportion of accelerations during the first stage. These subtle drug-induced effects do not compromise intrapartum decision-making or immediate newborn adjustments.
引用
收藏
页码:108 / 111
页数:4
相关论文
共 15 条
  • [1] *ACOG COMM, 2005, RIS DRINK ILL DRUG
  • [2] *AM COOLL OBST GYN, 2003, ACOG TECHNICAL B, V49
  • [3] American College of Obstetricians and Gynecologists, 1995, ACOG TECHN B, V207
  • [4] Assessment of fetal well-being in methadone-maintained pregnancies: Abnormal nonstress tests
    Anyaegbunam, A
    Tran, T
    Jadali, D
    Randolph, G
    Mikhail, MS
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1997, 43 (01) : 25 - 28
  • [5] ARCHIE CL, 1989, OBSTET GYNECOL, V74, P254
  • [6] Maternal methadone dose and neonatal withdrawal
    Berghella, V
    Lim, PJ
    Hill, MK
    Cherpes, J
    Chennat, J
    Kaltenbach, K
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (02) : 312 - 317
  • [7] Cejtin HE, 1996, J REPROD MED, V41, P819
  • [8] Relationship between maternal methadone dosage and neonatal withdrawal
    Dashe, JS
    Sheffield, JS
    Olscher, DA
    Todd, SJ
    Jackson, GL
    Wendel, GD
    [J]. OBSTETRICS AND GYNECOLOGY, 2002, 100 (06) : 1244 - 1249
  • [9] DOBERCZAK TM, 1993, OBSTET GYNECOL, V81, P936